Cargando…
Pathological Mechanisms and Preventive Strategies of Oxaliplatin-Induced Peripheral Neuropathy
Oxaliplatin, which is widely used in treating cancers such as colorectal cancer, frequently causes peripheral neuropathy. It not only significantly reduces the patient's quality of life due to physical distress but may also result in a change or discontinuation of cancer treatment. Oxaliplatin-...
Autor principal: | Egashira, Nobuaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8915546/ https://www.ncbi.nlm.nih.gov/pubmed/35295491 http://dx.doi.org/10.3389/fpain.2021.804260 |
Ejemplares similares
-
Impact of Dose, Sex, and Strain on Oxaliplatin-Induced Peripheral Neuropathy in Mice
por: Warncke, Urszula O., et al.
Publicado: (2021) -
Pathological Mechanisms of Bortezomib-Induced Peripheral Neuropathy
por: Yamamoto, Shota, et al.
Publicado: (2021) -
Exenatide Facilitates Recovery from Oxaliplatin-Induced Peripheral Neuropathy in Rats
por: Fujita, Shunsuke, et al.
Publicado: (2015) -
Drug Repositioning for the Prevention and Treatment of Chemotherapy-Induced Peripheral Neuropathy: A Mechanism- and Screening-Based Strategy
por: Yamamoto, Shota, et al.
Publicado: (2021) -
Therapeutic Agents for Oxaliplatin-Induced Peripheral Neuropathy; Experimental and Clinical Evidence
por: Kawashiri, Takehiro, et al.
Publicado: (2021)